Celadon Pharmaceuticals Plc (CEL.L)
GBp 7.0
(7.69%)
GBp 7.0
(7.69%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.12 GBP | 60.0% |
| 2022 | -0.30 GBP | 53.13% |
| 2021 | -0.64 GBP | -178.26% |
| 2020 | -0.23 GBP | -707.02% |
| 2019 | -0.03 GBP | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.02 GBP | 19.21% |
| 2024 Q2 | -0.02 GBP | 0.0% |
| 2023 Q2 | -0.07 GBP | -99.71% |
| 2023 FY | - GBP | 60.0% |
| 2023 Q3 | -0.02 GBP | 67.14% |
| 2023 Q1 | -0.03 GBP | 42.79% |
| 2023 Q4 | -0.02 GBP | 0.0% |
| 2022 Q2 | -0.25 GBP | -92.31% |
| 2022 Q1 | -0.13 GBP | -323.45% |
| 2022 FY | - GBP | 53.13% |
| 2022 Q4 | -0.06 GBP | -100.0% |
| 2022 Q3 | -0.03 GBP | 87.8% |
| 2021 FY | - GBP | -178.26% |
| 2021 Q2 | -0.02 GBP | 33.94% |
| 2021 Q4 | -0.03 GBP | -429.31% |
| 2021 Q1 | -0.03 GBP | 99.73% |
| 2021 Q3 | -0.01 GBP | 73.39% |
| 2020 Q4 | -12.21 GBP | -85284.62% |
| 2020 Q2 | -0.02 GBP | -77.3% |
| 2020 Q1 | -0.01 GBP | 0.0% |
| 2020 FY | - GBP | -707.02% |
| 2020 Q3 | -0.01 GBP | 42.8% |
| 2019 Q3 | -0.01 GBP | 0.0% |
| 2019 FY | - GBP | 0.0% |
| 2019 Q1 | -0.03 GBP | 0.0% |
| Name | Eps | Eps Difference |
|---|